BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30583216)

  • 21. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
    Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
    Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice by inducing CD4
    An K; Xue MJ; Zhong JY; Yu SN; Lan TS; Qi ZQ; Xia JJ
    J Neuroinflammation; 2020 May; 17(1):147. PubMed ID: 32375831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population.
    Li H; Nourbakhsh B; Ciric B; Zhang GX; Rostami A
    J Immunol; 2010 Oct; 185(7):4095-100. PubMed ID: 20805418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise training attenuates experimental autoimmune encephalomyelitis by peripheral immunomodulation rather than direct neuroprotection.
    Einstein O; Fainstein N; Touloumi O; Lagoudaki R; Hanya E; Grigoriadis N; Katz A; Ben-Hur T
    Exp Neurol; 2018 Jan; 299(Pt A):56-64. PubMed ID: 29031957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
    Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
    J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The change of periphery and centra CD4(+);CD25(+);Treg, CD8(+);CD28(-);Treg in the MOG induced model of experimental autoimmune encephalomyelitis].
    Shang XF; Xi NN; Wang T; Lv J; Han Z; Zheng RY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Aug; 26(8):746-9. PubMed ID: 20619099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione.
    Singh I; Nath N; Saxena N; Singh AK; Won JS
    Immunobiology; 2018 Oct; 223(10):549-554. PubMed ID: 29960806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.
    Saxena N; Won J; Choi S; Singh AK; Singh I
    Free Radic Biol Med; 2018 Jun; 121():57-68. PubMed ID: 29694854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system.
    Zhang GX; Gran B; Yu S; Li J; Siglienti I; Chen X; Kamoun M; Rostami A
    J Immunol; 2003 Feb; 170(4):2153-60. PubMed ID: 12574388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system.
    Chen Q; Liu Y; Lu A; Ni K; Xiang Z; Wen K; Tu W
    J Autoimmun; 2017 Feb; 77():1-10. PubMed ID: 28341037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
    Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation.
    Veremeyko T; Yung AWY; Dukhinova M; Kuznetsova IS; Pomytkin I; Lyundup A; Strekalova T; Barteneva NS; Ponomarev ED
    Front Immunol; 2018; 9():50. PubMed ID: 29422898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous and interval training attenuate encephalomyelitis by separate immunomodulatory mechanisms.
    Goldberg Y; Fainstein N; Zaychik Y; Hamdi L; Segal S; Nabat H; Touloumi O; Zoidou S; Grigoriadis N; Hoffman JR; Katz A; Ben-Hur T; Einstein O
    Ann Clin Transl Neurol; 2021 Jan; 8(1):190-200. PubMed ID: 33285042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
    Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
    J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anlotinib attenuates experimental autoimmune encephalomyelitis mice model of multiple sclerosis
    Zhu H; Li G; Yin J; Zhang H; Da Y; Li L
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):594-602. PubMed ID: 35638564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.